Author: Dayan Goodenowe

Publisher: Independently Published

Published: 2021-06-21

Total Pages: 244

ISBN-13:

Breaking Alzheimer's is Dr. Dayan Goodenowe's story of personal and scientific perseverance. The biochemical mechanisms of neurological disease is his area of expertise and was his area of expertise for 15 years before he serendipitously discovered that low plasmalogen levels were causing Alzheimer's. Dr. Goodenowe had never heard of plasmalogens and he had never been taught about them. There are now 15 years of supportive validation of this discovery and access to plasmalogen testing and supplementation is now available to everyone. By sheer will, Dr. Goodenowe has completed the beginning and the middle of this journey such that the plasmalogen genie cannot be put back in the bottle. This book is about bringing the reader up to speed as to where we currently are on this journey and where we are going from here. The Breaking Alzheimer's Video Series and Audio Book will be available through Dr. Dayan Goodenowe's website soon. Learn more about Dr. Goodenowe and his educational content here: https: //drgoodenowe.com To learn more about Dr. Goodenowe's scientifically designed supplements and blood testing technology visit the Prodrome Sciences website here: https: //prodrome.com ADVANCE PRAISE "A paradigm-altering view of Alzheimer's." Dale Bredesen, MD Author of The New York Times Bestseller The End of Alzheimer's "A brilliant and ground-breaking text on the science and clinical application of plasmalogens for the therapeutic amelioration of Alzheimer's Dementia. I have had the good fortune of observing firsthand the significant, clinical benefits in my patients with neurodegenerative disorders for whom I've prescribed plasmalogen therapy." Mitchel Fleisher M.D., D.Ht., D.A.B.F.M., Dc.A.B.C.T. Medical Director, Center for Integrative & Regenerative Medicine "A bold and promising approach. Dr. Goodenowe has performed groundbreaking and compelling research which is detailed in the book so that afflicted patients and health professionals will become aware of a discovery which may very well change our approach to Alzheimer's. We have been deploying plasmalogen precursors at the Regenesis Project and have found that within the timeframe of a few weeks, people become more alert and cognizant." Sheldon Jordan, MD, FAAN, DABPN, DABCN Medical Director, the Regenesis Project "Dr. Goodenowe has not only identified a biomarker-plasmalogen-that is strongly correlated with dementia, but he has also discovered a way to track and improve that marker allowing ApoE4 carriers, at the highest genetic risk for Alzheimer's, to potentially avoid disease onset. Indeed, many of our members have had a noticeable improvement after addressing low levels." Julie Gregory Founder & President of ApoE4.Info "I strongly recommend this book which I hope will be as transformative for you as it has been for me. It is easy to read and understand and will impact your everyday decision making." Bijan Pourat MD ACC FRCP(C) "Dayan Goodenowe has drilled down to the very core of what makes us tick. His patient 25 year journey of research and invention has unpacked unique and marvelous understanding into how our metabolic engine works. We have a whole new field of medicine opening up called "metabolic medicine" and it runs right through Dr. Goodenowe's inventions. Like tuning your carburetor and timing your engine, we can now heal your mitochondria and make your peroxisomes whistle with the careful measurement and replacement of plasmalogens. The implications of his inventions can't be overstated. This is the end of Alzheimer's, Parkinson's, cancer....and who knows what lies ahead in the paradigm shift to true wellness with the absence of disease." John E. Whitcomb, MD Brookfield Longevity Medical Clinic